EcoDrugPlus

Integrin Subunit Beta 8

Ensembl ID : ENSCAFG00020002163
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSCAFG00020024415
Gene Symbol: ICAM1
3 Cross references
88 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSCAFG00020010511
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSCAFG00020014298
Gene Symbol: IL5
3 Cross references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSCAFG00020002653
Gene Symbol: IL6
3 Cross references
162 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSCAFG00020027389
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSCAFG00020016405
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSCAFG00020000492
Gene Symbol: KLKB1
3 Cross references
209 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSCAFG00020024476
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSCAFG00020000430
Gene Symbol: KDR
3 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCAFG00020002242
Gene Symbol: KIF11
3 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSCAFG00020026240
Gene Symbol: KIF5B
3 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).